FDA Update & Product News

JANUARY 16, 2024

FDA Warns About Counterfeit Ozempic Found in U.S. Drug Supply Chain

The FDA reported counterfeit semaglutide (Ozempic, Novo Nordisk) was found in the legitimate U.S. drug supply chain and has seized thousands of units of the product.

To read the full story, Log in or Sign up for a Free Account

First Name

Last Name

Organization/Institution

State

NPI	Name	Organization/ Institution	State	Zip Code	Taxonomy	Credential	Select